Dermatology Data Support Relative Safety of JAK Inhibitors

Nearly 10 years after the first JAK inhibitor was approved for a dermatologic disorder, more uses are imminent, with fewer safety concerns.
Medscape Medical News

source https://www.medscape.com/viewarticle/dermatology-emerging-data-support-relative-safety-jak-2025a10010mv?src=rss